0000899243-21-024300.txt : 20210616 0000899243-21-024300.hdr.sgml : 20210616 20210616200726 ACCESSION NUMBER: 0000899243-21-024300 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biomatics Capital Partners, L.P. CENTRAL INDEX KEY: 0001672431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40489 FILM NUMBER: 211023005 BUSINESS ADDRESS: STREET 1: 719 SECOND AVENUE STREET 2: SUITE 1402 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 703-966-0695 MAIL ADDRESS: STREET 1: 719 SECOND AVENUE STREET 2: SUITE 1402 CITY: SEATTLE STATE: WA ZIP: 98104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verve Therapeutics, Inc. CENTRAL INDEX KEY: 0001840574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824800132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (978) 501-3026 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-06-16 0 0001840574 Verve Therapeutics, Inc. VERV 0001672431 Biomatics Capital Partners, L.P. 188 E. BLAINE STREET, SUITE 126 SEATTLE WA 98102 0 0 1 0 Series A Preferred Stock Common Stock 1535077 D Series A-2 Preferred Stock Common Stock 973734 D Series B Preferred Stock Common Stock 88653 D Each share of the Issuer's preferred stock is convertible into common stock on an approximately 9.2595-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. These shares are held by Biomatics Capital Partners, LP ("Biomatics LP"). Biomatics Capital Management, L.L.C. ("Biomatics GP") is the general partner of Biomatics LP. Julie Sunderland and Boris Nikolic ( the "Managing Members") are the managing members of Biomatics GP. Each of the Managing Members may be deemed to share voting and dispositive power over these shares. Each of the Managing Members and Biomatics GP disclaim beneficial ownership of these shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. /s/ Julie Sunderland, Managing Member of Biomatics Capital Management, L.L.C., the general partner of Biomatics Capital Partners, LP. 2021-06-16